Detalhe da pesquisa
1.
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR).
Br J Haematol
; 202(1): 40-47, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971061
2.
COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Ann Hematol
; 102(4): 811-817, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36847805
3.
Burkitt lymphoma-a retrospective analysis of data from the Registry of the Czech Lymphoma Study Group with external validation of the Burkitt lymphoma International Prognostic Index.
Neoplasma
; 69(6): 1466-1473, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591807
4.
Skipping a step: what happened to the design of randomized clinical trials in chronic lymphocytic leukaemia?
Br J Haematol
; 193(4): 723-726, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33216352
5.
External validation of International Prognostic Score for asymptomatic early stage chronic lymphocytic leukaemia and proposal of an alternative score.
Br J Haematol
; 193(1): 133-137, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33280081
6.
Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group.
Br J Haematol
; 193(4): 769-778, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618437
7.
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Eur J Clin Invest
; 51(4): e13421, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33022756
8.
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
Hematol Oncol
; 38(4): 509-516, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32400885
9.
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia.
Ann Hematol
; 98(12): 2749-2760, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31745601
10.
On the road to optimized BTK inhibition in CLL.
Blood
; 137(24): 3313-3314, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34137848
11.
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.
Haematologica
; 103(7): 1209-1217, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674504
12.
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Oncol
; 18(3): 297-311, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28139405
13.
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLL.
Am J Hematol
; 91(9): 900-6, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27222473
14.
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.
Lancet Oncol
; 16(13): 1370-9, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26377300
15.
Incidence and prognostic significance of serum immunoglobulins and paraproteins in patients with chronic lymphocytic leukaemia: another valuable piece of the puzzle.
Br J Haematol
; 190(6): 815-816, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686123
16.
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
Br J Haematol
; 170(1): 40-9, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25825041
17.
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic Leukemia.
Haematologica
; 100(4): 511-6, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596264
18.
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study.
Am J Hematol
; 90(5): 417-21, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25645263
19.
[Rituximab infusion-related toxicity in patients with chronic lymphocytic leukemia]. / Infuzní toxicita rituximabu u nemocných s chronickou lymfocytární leukemií.
Vnitr Lek
; 61(7-8): 626-32, 2015.
Artigo
em Tcheco
| MEDLINE | ID: mdl-26375688
20.
Refining prognosis after first-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy in chronic lymphocytic leukaemia.
Lancet Oncol
; 20(11): 1478-1479, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582352